Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Kalantari

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Experimental Pathology|May 16, 2019
Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancerElham Kalantari, Maryam Abolhasani, Raheleh Roudi, et al.
Cancer Biomarkers : Section a of Disease Markers|March 20, 2025
Clinical significance of "S" isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibodyMahdieh Razmi, Ali-Ahmad Bayat, Nafiseh Mortazavi, et al.
Iranian Journal of Pathology|November 9, 2023
The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma PatientsMina Sharbatoghli, Leili Saeednejad Zanjani, Fattahi Fahimeh, et al.
BMC Cancer|June 20, 2020
A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignanciesMohammad Ali Zolfaghari, Abbas Karimi, Elham Kalantari, et al.
ACS Pharmacology & Translational Science|December 18, 2025
Fibroblast Activation Protein Inhibitor (FAPI)-Radioligand PET/CT in the Assessment of Nononcological Diseases: A Narrative ReviewForough Kalantari, Anton Amadeus Hörmann, Martha Pokarowski, et al.
Cancer Biomarkers : Section a of Disease Markers|March 23, 2018
Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancerMaryam Khorasani, Ladan Teimoori-Toolabi, Taghi Naserpour Farivar, et al.
Frontiers in Cellular and Infection Microbiology|March 14, 2022
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the PandemicSamaneh Pourajam, Elham Kalantari, Hamid Talebzadeh, et al.
Journal of Ovarian Research|January 29, 2022
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinomaMina Sharbatoghli, Parisa Shamshiripour, Fahimeh Fattahi, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 29, 2024
Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumoursNiknam Lakpour, Roya Ghods, Maryam Abolhasani, et al.
Clinical Breast Cancer|October 20, 2023
Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast CancerMasoud Hassanzadeh Makoui, Maryam Mobini, Shiva Fekri, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Experimental Pathology|May 16, 2019
Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancerElham Kalantari, Maryam Abolhasani, Raheleh Roudi, et al.
Cancer Biomarkers : Section a of Disease Markers|March 20, 2025
Clinical significance of "S" isoform of DCLK1 in different gastric cancer subtypes using newly produced monoclonal antibodyMahdieh Razmi, Ali-Ahmad Bayat, Nafiseh Mortazavi, et al.
Iranian Journal of Pathology|November 9, 2023
The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma PatientsMina Sharbatoghli, Leili Saeednejad Zanjani, Fattahi Fahimeh, et al.
BMC Cancer|June 20, 2020
A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignanciesMohammad Ali Zolfaghari, Abbas Karimi, Elham Kalantari, et al.
ACS Pharmacology & Translational Science|December 18, 2025
Fibroblast Activation Protein Inhibitor (FAPI)-Radioligand PET/CT in the Assessment of Nononcological Diseases: A Narrative ReviewForough Kalantari, Anton Amadeus Hörmann, Martha Pokarowski, et al.
Cancer Biomarkers : Section a of Disease Markers|March 23, 2018
Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancerMaryam Khorasani, Ladan Teimoori-Toolabi, Taghi Naserpour Farivar, et al.
Frontiers in Cellular and Infection Microbiology|March 14, 2022
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the PandemicSamaneh Pourajam, Elham Kalantari, Hamid Talebzadeh, et al.
Journal of Ovarian Research|January 29, 2022
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinomaMina Sharbatoghli, Parisa Shamshiripour, Fahimeh Fattahi, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 29, 2024
Higher expression of SALL4-A isoform is correlated with worse outcomes and progression of the disease in subtype of testicular germ cell tumoursNiknam Lakpour, Roya Ghods, Maryam Abolhasani, et al.
Clinical Breast Cancer|October 20, 2023
Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast CancerMasoud Hassanzadeh Makoui, Maryam Mobini, Shiva Fekri, et al.
Pageof 4